Asthma and Chronic obstructive pulmonary disease (COPD) are two of the most researched diseases, but progress in finding new, more effective treatments has been disappointing.
A solution could be to use personalised treatment. In other words, each person could get a medicine based on the specific type of asthma or COPD they have. This takes into account the fact that everyone is different, and medicines can work in people in different ways. Working out how to use personalised treatment in people with asthma or COPD could help people to find the best, most effective medicine for them more easily.
The NOVELTY study has the benefit of including a range of people and collecting many different types of information over time. This is important, as studying a variety of people will help us to understand the different types of asthma and COPD and how different treatments affect them.
Improving our understanding of the different types of asthma and COPD is an essential step towards making personalised treatment a reality.